A microRNA is a tiny non-coding RNA molecule that is found in animals, plants as well as some viruses, that is utilized in post-transcriptional regulation of gene expression and RNA silencing. The overall market is likely to account for a robust growth owing to growing demand for microRNA re-agents in addition to kits for a range of applications which could in due course interpret into initial innovative therapeutic solutions for different difficult to cure illnesses. In terms of value, it is estimated to record a CAGR of 7.9% during the eight-year calculated period 2025.

Market Segmentation

Based on assay type, the overall market is segmented into miRNA Arrays, PCR-based assay, next-generation sequencing (NGS) and immune assay (which is further categorized into colorimetric assays, fluorescent assays and chemiluminescent assays). PCR based arrays segment will be accounting for 36.9% by the end of 2025, followed by next-generation sequencing segment and is estimated to record an 8.1% CAGR throughout the projection period.

Request For Report Sample: https://www.researchreportinsights.com/report/sample/110114980/MicroRNA-Market

The application of the microRNA is mainly into research and clinical diagnostics. The research segment is considered as the biggest in the overall market by accounting for about US$ 525.6 Million by the end of 2025, up from US$ 275.7 Million in the year 2017. It is also expected to record an 8.4% CAGR over the calculated period.

The end users of the microRNA include biopharmaceutical companies, academic and research institutes, diagnostic centers and contract research organizations. The academic & research institutes are the most lucrative segment in overall microRNA market, it is expected to be accounting for about US$ 255.9 Million by the end of the forecast year 2025, up from US$ 138.9 Million in 2017 in terms of value. It is projected to register a CAGR of 7.9% throughout 2017-2025.

On the basis of region, the overall market is studied across five key regions including Latin America, North America, Asia Pacific, Europe and Middle East & Africa. North America is considered to be the most lucrative region among other regions and is likely to reach US$ 245.9 Million by 2025, exhibiting a 7.3% CAGR during 2017-2025, followed by Europe.

Key Market Players

The overall market for microRNA has at present the following prominent players

• Agilent Technologies

• F. Hoffmann-La Roche Ltd

• Illumina, Inc.

• Sigma Aldrich Corp.

• Thermo Fisher Scientific, Inc.

• Qiagen N.V

Request Report Discount: https://www.researchreportinsights.com/report/discount/110114980/MicroRNA-Market

• Rosetta Genomics Ltd.

• HTG Molecular Diagnostics, Inc.

• Bio-Rad Laboratories Inc.

• Dharmacon, a Horizon Discovery Group Co.

• System Biosciences LLC

• Bioline GmbH (A Meridian Life Science Company)

• Miltenyi Biotec

• BioVendor — Laboratorní medicína a.s.

• Abcam Plc

• New England Biolabs, Inc.

• Kaneka Corporation (Eurogentec)

• Promega Corporation

• GeneCopoeia, Inc.

• NanoString Technologies, Inc



Report Analysis: https://www.researchreportinsights.com/report/rd/110114980/MicroRNA-Market